Teradata Corp Files 8-K on Financials
Ticker: TDC · Form: 8-K · Filed: Nov 4, 2025 · CIK: 816761
| Field | Detail |
|---|---|
| Company | Teradata Corp /De/ (TDC) |
| Form Type | 8-K |
| Filed Date | Nov 4, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: TDC
TL;DR
Teradata dropped an 8-K on Nov 4th covering financials - check it out.
AI Summary
On November 4, 2025, Teradata Corporation filed an 8-K report detailing results of operations and financial condition, along with financial statements and exhibits. The filing was made pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. The report includes information on the company's financial performance and related exhibits.
Why It Matters
This filing provides investors with crucial updates on Teradata's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not appear to contain any immediate adverse news.
Key Players & Entities
- TERADATA CORP /DE/ (company) — Registrant
- November 4, 2025 (date) — Date of Report
- 001-33458 (other) — Commission File Number
- 75-3236470 (other) — I.R.S. Employer Identification No.
- 17095 Via Del Campo San Diego , California 92127 (address) — Principal executive offices
- ( 866 ) 548-8348 (phone_number) — Registrant's telephone number
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is November 4, 2025.
What is Teradata Corporation's Commission File Number?
Teradata Corporation's Commission File Number is 001-33458.
Where are Teradata Corporation's principal executive offices located?
Teradata Corporation's principal executive offices are located at 17095 Via Del Campo, San Diego, California 92127.
Under which sections of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 1,112 words · 4 min read · ~4 pages · Grade level 15.9 · Accepted 2025-11-04 16:11:55
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value TDC New York Stock Exchange
Filing Documents
- tdc-20251104.htm (8-K) — 32KB
- tdc09302025exhibit991.htm (EX-99.1) — 481KB
- image1.jpg (GRAPHIC) — 8KB
- 0001628280-25-048834.txt ( ) — 668KB
- tdc-20251104.xsd (EX-101.SCH) — 2KB
- tdc-20251104_lab.xml (EX-101.LAB) — 21KB
- tdc-20251104_pre.xml (EX-101.PRE) — 12KB
- tdc-20251104_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. Teradata Corporation ("Teradata" or the "Company") is furnishing the following information as required under Item 2.02 "Results of Operations and Financial Condition" of Form 8-K. Such information, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. On November 4, 2025, the Company issued a press release setting forth its third quarter of fiscal year 2025 operating results as well as current outlook estimates for the fourth quarter of 2025 and for the full-year 2025 (the "Earnings Press Release"). A copy of the Earnings Press Release is attached hereto as Exhibit 99.1 and hereby incorporated by reference. The Company also posted supplemental material dat ed November 4, 2025 , on the Investor Relations page of its website at investor.teradata.com. Except as specifically noted herein, information on the Company's website is not, and will not be deemed to be, a part of this Current Report on Form 8-K or incorporated into any other filings the Company may make with the Securities and Exchange Commission.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits: The following exhibits are attached with this current report on Form 8-K: Exhibit No. Description 99.1 Press Release, dated November 4 , 2025 , issued by the Company (Earnings Press Release). 104 Cover Page Interactive Data (embedded within the Inline XBRL document). Safe Harbor Statement This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 21E of the Securities and Exchange Act of 1934. Forward-looking statements generally relate to opinions, beliefs, and projections of expected future financial and operating performance, business trends, liquidity, and market conditions, among other things. These forward-looking statements are based upon current expectations and assumptions and often can be identified by words such as "expect," "strive," "looking ahead," "outlook," "guidance," "forecast," "anticipate," "continue," "plan," "estimate," "believe," "focus," "see," "commit," "should," "project," "will," "would," "likely," "intend," "potential," or similar expressions. All statements, other than statements of historical facts, included in this Current Report on Form 8-K which address activities, events or developments that the Company expects or anticipates will or may occur in the future, including statements about our 2025 fourth quarter and full year 2025 financial outlook in the accompanying press release are forward-looking statements. These forward-looking statements are based upon current expectations and assumptions and involve risks and uncertainties that could cause the Company's actual results to differ materially. In addition to the factors discussed in this Form 8-K filing, other risks and uncertainties could affect the Company's future results, and could cause actual results to differ materially from those expressed in such forward-looking statements, including those relating to: the global economic environment and business conditions in gene
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. TERADATA CORPORATION Date: November 4, 2025 By: /s/ John Ederer John Ederer Chief Financial Officer